Skip to main content
SpringerLink
Log in

The Adrenals in Oncology

  • Chapter
  • First Online:
Adrenal Imaging

Part of the book series: Contemporary Medical Imaging ((CMI))

  • 1098 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moore K, Agur A (2002) Essential clinical anatomy. Lippincott Williams and Wilkins, pp 182–185

    Google Scholar 

  2. Rouvière H (1932) Anatomie des lymphatiques de l'homme. Masson

    Google Scholar 

  3. Young WF (2000) Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185

    Article  PubMed  Google Scholar 

  4. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460–484

    PubMed  CAS  Google Scholar 

  5. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M (2006) Prevalence of adrenal incidentaloma in a contempory computerised tomography series. J Endocrinol Invest 29:298–302

    PubMed  CAS  Google Scholar 

  6. Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma. Cancer 3:74–84

    Article  PubMed  CAS  Google Scholar 

  7. Glomset DA (1938) The incidence of metastases of malignant tumours to the adrenals. Am J Med Sci 226:521–530

    Google Scholar 

  8. Cedermark BJ, Blumenson LE, Pickren JW, Elias EG (1977) The significance of metastasis to the adrenal gland from carcinoma of the stomach and oesophegus. Surg Gynaecol Obstet 145:41–48

    CAS  Google Scholar 

  9. Lutz A, Stojkovic M, Schmidt M, Arlt W, Allolio B, Reincke M (2000) Adrenocortical function in patients with macrometastases of the adrenal gland. Eur J Endocrinol 143:91–97

    Article  PubMed  CAS  Google Scholar 

  10. Vincent JM, Morrison ID, Armstrong P, Reznek RH (1994) Computed tomography of diffuse, non-metastatic enlargement of the adrenal glands in patients with malignant disease. Clin Radiol 49:456–460

    Article  PubMed  CAS  Google Scholar 

  11. Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R (1999) Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer 80:1815–1819

    Article  PubMed  CAS  Google Scholar 

  12. Biswas M, Smith JC, Davies JS (2004) Bilateral adrenal enlargement and non-suppressible hypercortisolism as a presenting feature of gastric cancer. Ann Clin Biochem 41:494–497

    Article  PubMed  CAS  Google Scholar 

  13. Wajchenberg BL, Albergaria-Pereira MA, Medonca BB, Latronico AC, Campo-Carneiro P, Alves VA, Zerbini MC, Liberman B, Carlos-Gomes G, Kirschner MA (2000) Adrenocortical carcinoma: clinical and laboratory observations . Cancer 88:711–736

    Article  PubMed  CAS  Google Scholar 

  14. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91:2650–2655

    Article  PubMed  CAS  Google Scholar 

  15. Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update J Clin Endocrinol Metab 91:2027–2037

    Article  PubMed  CAS  Google Scholar 

  16. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362

    PubMed  CAS  Google Scholar 

  17. Wiedemann H (1964) Complexe malformatif familial avec hernie ombilicale et macroglossie, un “syndrome nouveau” J Genet Hum 13:223

    CAS  Google Scholar 

  18. Sidhu S, Sywak M, Robinson B, Delbridge L (2004) Adrenocortical cancer: recent clinical and molecular advances. Curr Opin Oncol 16:13–18

    Article  PubMed  Google Scholar 

  19. Koch CA, Pacak K, Chrousos GP (2002) The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 87:5367–5384

    Article  PubMed  CAS  Google Scholar 

  20. Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF (1978) Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer 41:2055–2064

    Article  PubMed  CAS  Google Scholar 

  21. Ohgaki H, Kleihues P, Heitz PU (1993) p53 mutations in sporadic adrenocortical tumours. Int J Cancer 54:408–410

    Article  PubMed  CAS  Google Scholar 

  22. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM, Chrousos GP (1994) p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab 78:790–794

    Article  PubMed  CAS  Google Scholar 

  23. Barzon L, Chilosi M, Fallo F, Martignoni G, Montagna L, Palu G, Boscaro M (2001) Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Eur J Endocrinol 145:207–212

    Article  PubMed  CAS  Google Scholar 

  24. Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72:3145–3155

    Article  PubMed  CAS  Google Scholar 

  25. Haak HR, Hermans J, van de Velde CJ et al. (1994) Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients [see comment]. Br J Cancer 69:947–951

    Article  PubMed  CAS  Google Scholar 

  26. Norton J (1997) Adrenal tumors. Cancer: Principles and Practice of Oncology. Lippincott-Raven, Philadelphia, vol 1659, p77

    Google Scholar 

  27. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR (1998) Characterisation of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201–204

    PubMed  CAS  Google Scholar 

  28. Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, Meuller PR (1995) Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194:131–134

    PubMed  CAS  Google Scholar 

  29. Maurea S, Mainolfi C, Bazzicalupo L, Panico MR, Imparato C, Alfano B, Ziviello M, Salvatore M (1999) Imaging of adrenal tumours using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173:25–29

    PubMed  CAS  Google Scholar 

  30. Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, Kung J, Huang H, Alavi A (2004) 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 45:2058–2062

    PubMed  Google Scholar 

  31. Saeger W (2000) Histopathological classification of adrenal tumours. Eur J Clin Invest 30(Suppl 3):58–62

    Article  PubMed  Google Scholar 

  32. Ross NS, Aron DC (1990) Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Eng J Med 323:1401–1405

    Article  CAS  Google Scholar 

  33. Weiss LM (1984) Comparative histologic study of 43 metastasising and nonmetasising adrenocortical tumours. Am J Surg Pathol 8:163–169

    Article  PubMed  CAS  Google Scholar 

  34. Hough AJ, Hollifield JW, Page DL, Hartmann WH (1979) Prognostic factors in adrenal cortical tumours. A mathematical analysis of clinical and morphological data. Am J Clin Path 72:390–399

    PubMed  CAS  Google Scholar 

  35. Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M, Leteurte E (2002) Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumours. Am J Surg Pathol 26:1621–1629

    Article  Google Scholar 

  36. McNicol AM, Nolan CE, Struthers AJ, Farquharson MA, Hermans J, Haak HR (1997) Expression of p53 in adrenocortical tumours: clinicopathological correlations. J Pathol 181:146–152

    Article  PubMed  CAS  Google Scholar 

  37. Wachenfield C, Beuschlein F, Zwermann O, Mora P, Fassnacht M, Allolio B, Reincke M (2001) Discerning malignancy in adrenocortical tumours: are molecular markers useful? Eur J Endocrinol 145:335–341

    Article  Google Scholar 

  38. Tissier F, Louvel A, Grabar S, Hagnere AM, Bertherat J, Vacher-Lavenu MC, Dousset B, Chapuis Y, Bertagna X, Gicquel C (2004) Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumours. Eur J Endocrinol 150:809–817

    Article  PubMed  CAS  Google Scholar 

  39. Dousset B, Gaujoux S, Thillois J-M (2006) Surgical treatment of adrenal cortical carcinoma. In: Bertagna X (ed) Adrenal cancer. John Libbey Eurotext, pp 71–95

    Google Scholar 

  40. Pommier RF, Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma: Surgery 112(6):963–970; discussion 970–971

    PubMed  CAS  Google Scholar 

  41. Luton JP, Cerdas S, Billaud L et al. (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy [see comment]. N Engl J Med 322:1195–1201

    Article  PubMed  CAS  Google Scholar 

  42. Vassilopoulou-Sellin R, Guinee VF, Klein MJ et al. (1993) Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer [see comment]. Cancer 71:3119–3123

    Article  PubMed  CAS  Google Scholar 

  43. Ahlman H, Khorram-Manesh A, Jansson S et al. (2001) Cytotoxic treatment of adrenocortical carcinoma. World J Surg 25:927–933

    Article  PubMed  CAS  Google Scholar 

  44. Berruti A, Terzolo M, Sperone P et al. (2005) Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Rel Cancer 12:657–666

    Article  CAS  Google Scholar 

  45. Chacon R, Tossen G, Loria F, Chacon M (2005) CASE 2. Response in a patient with metastatic adrenal cortical carcinoma with thalidomide. J Clin Oncol 1 23:1579–1580

    Article  Google Scholar 

  46. Magee BJ, Gattamaneni HR, Pearson D (1987) Adrenal cortical carcinoma: survival after radiotherapy. Clin Radiol 38:587–588

    Article  PubMed  CAS  Google Scholar 

  47. Percarpio B, Knowlton AH (1976) Radiation therapy of adrenal cortical carcinoma. Acta Radiol Ther Phys Biol 15:288–292

    PubMed  CAS  Google Scholar 

  48. Markoe AM, Serber W, Micaily B, Brady LW (1991) Radiation therapy for adjunctive treatment of adrenal cortical carcinoma. Am J Clin Oncol 14:170–174

    Article  PubMed  CAS  Google Scholar 

  49. Fassnacht M, Hahner S, Polat B, Koschker AC, Kenn W, Flentje M, Allolio B (2006) Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma J Clin Endocrinol Metab 91:4501–4504

    Article  PubMed  CAS  Google Scholar 

  50. Cryer PE (1985) Phaeochromocytoma. Clin Endocrinol Metab 14:203–220

    Article  PubMed  CAS  Google Scholar 

  51. Beierwaltes WH, Sisson JC, Shapiro B (1986) Malignant potential of pheochromocytoma. Proc AACR 27:617

    Google Scholar 

  52. Melicow MM (1987) One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926–1976: a clinicopathological analysis. Cancer 40:1987–2004

    Article  Google Scholar 

  53. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C (2002) Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. 2002 Germ-line mutations in nonsyndromic pheochromocytoma N Engls J Med 346:1459–1466

    CAS  Google Scholar 

  54. Nakagawara A, Ikeda K, Tsuneyoshi M, Daimaru Y, Enjoji M (1985) Malignant pheochromocytoma with ganglioneuroblastoma elements in a patient with von Recklinghausen's disease. Cancer 55:2794–2798

    Article  PubMed  CAS  Google Scholar 

  55. Loughlin KR, Gittes RF (1986) Urological management of patients with von Hippel-Lindau's disease. J Urol 136:789–791

    PubMed  CAS  Google Scholar 

  56. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C, Maher ER (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am J Hum Genet 69:49–54

    Article  PubMed  CAS  Google Scholar 

  57. Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG, Eng C, Latif F, Maher ER (2001) Germline SDHD mutation in familial phaeochromocytoma Lancet 357:1181–1182

    CAS  Google Scholar 

  58. Stein PP, Black HR (1991) A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine 70:46–66

    Google Scholar 

  59. Bravo EL (1991) Pheochromocytoma: new concepts and future trends. Kidney Int 40:544–556

    Article  PubMed  CAS  Google Scholar 

  60. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS (2005) International Symposium on Pheochromocytoma. 2005 Pheochromocytoma: recommendations for clinical practice from the First International Symposium Nat Clin Pract Endocrinol Metab 3:92–102

    Google Scholar 

  61. Bravo EL (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15:356–368

    PubMed  CAS  Google Scholar 

  62. Whalen RK, Althausen AF, Daniels GH (1992) Extra-adrenal pheochromocytoma. J Urol 147:1–10

    PubMed  CAS  Google Scholar 

  63. Cotran A, Kumar V, Robbins SL (1994) Robbins pathologic basis of disease, 5th edn. WB Saunders, Philadelphia, pp 1161–1164

    Google Scholar 

  64. Lo CY, Lam KY, Wat MS, Lam KS (2000) Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg 179:212–215

    Article  PubMed  CAS  Google Scholar 

  65. Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G (2001) Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center [see comment]. J Clin Endocrinol Metab 86:1480–1486

    Article  PubMed  CAS  Google Scholar 

  66. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF (2005) Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90:2110–2116

    Article  PubMed  CAS  Google Scholar 

  67. Shapiro B, Gross MD, Shulkin B (2001) Radioisotope diagnosis and therapy of malignant pheochromocytoma. Trend Endocrinol Metab 12:469–475

    Article  CAS  Google Scholar 

  68. Schlumberger M, Gicquel C, Lumbroso J et al. (1992) Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 15:631–642

    PubMed  CAS  Google Scholar 

  69. Safford SD, Coleman RE, Gockerman JP et al. (2003) Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery 134:956–962

    Article  PubMed  Google Scholar 

  70. Rose B, Matthay KK, Price D et al. (2003) High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 98:239–248

    Article  PubMed  CAS  Google Scholar 

  71. Loh KC, Fitzgerald PA, Matthay KK, Yeo PP, Price DC (1997) The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 20:648–658

    PubMed  CAS  Google Scholar 

  72. Shapiro B, Sisson JC, Wieland DM et al. (1991) Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 35:269–276

    PubMed  CAS  Google Scholar 

  73. Averbuch SD, Steakley CS, Young RC et al. (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 109:267–273

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Abdominal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, Boston, MA 02114

    Giles W. L. Boland

Authors
  1. Claire E. Higham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John J. Coen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giles W. L. Boland
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter J. Trainer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giles W. L. Boland .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Dept. Radiology, Harvard Medical School, Fruit St. 55, Boston, 02114, U.S.A.

    Michael A. Blake

  2. Massachusetts General Hospital, Dept. Radiology, Harvard Medical School, Fruit St. 55, Boston, 02114, U.S.A.

    Giles Boland

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Higham, C.E., Coen, J.J., Boland, G.W.L., Trainer, P.J. (2009). The Adrenals in Oncology. In: Blake, M., Boland, G. (eds) Adrenal Imaging. Contemporary Medical Imaging. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-560-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-560-2_4

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-934115-86-2

  • Online ISBN: 978-1-59745-560-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation